NCCN Guidelines® Insights - Dermatofibrosarcoma Protuberans, Version 1.2014
Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue tumor characterized by a relatively high risk of local recurrence and low risk of metastasis. The NCCN Guidelines for DFSP provide multidisciplinary recommendations on the management of patients with this rare disease. These NCCN Guidelines Insights highlight the addition of the Principles of Pathology section, which provides recommendations on the pathologic assessment of DFSP. Because DFSP can mimic other lesions, immunohistochemical studies are often required to establish diagnosis. Cytogenetic testing for the characteristic translocation t(17;22)(q22;q13) can also be valuable in the differential diagnosis of DFSP with other histologically similar tumors.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for Dermatofibrosarcoma Protuberans
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Dermatofibrosarcoma Protuberans
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician